Non-Myeloablative Allogeneic Transplantation

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Surgery
Cover of the book Non-Myeloablative Allogeneic Transplantation by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461509196
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461509196
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach may necessitate more careful monitoring of post-transplant chimerism and malignant disease-status than is usual with conventional allografting. There is also controversy regarding the best preparative regimen and graft-versus-host disease prophylaxis to use.

More books from Springer US

Cover of the book Silent Myocardial Ischemia by
Cover of the book Scalable Performance Signalling and Congestion Avoidance by
Cover of the book Process Control Systems by
Cover of the book Animal Bodies, Human Minds: Ape, Dolphin, and Parrot Language Skills by
Cover of the book French and Creole in Louisiana by
Cover of the book Product Design for Modularity by
Cover of the book Life Span Perspectives of Suicide by
Cover of the book Optical Character Recognition by
Cover of the book Enzyme-Prodrug Strategies for Cancer Therapy by
Cover of the book Issues in International Bilingual Education by
Cover of the book i386/i486 Advanced Programming by
Cover of the book Strategic Decisions by
Cover of the book Sexuality by
Cover of the book Manufacturing of Gene Therapeutics by
Cover of the book Progress in Motor Control by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy